<DOC>
	<DOC>NCT01391312</DOC>
	<brief_summary>This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in glabellar rhytides (frown lines) using a new treatment satisfaction measure.</brief_summary>
	<brief_title>Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate to severe glabellar wrinkles (frown lines) Previous treatment with botulinum toxin therapy of any serotype Facial nonablative resurfacing laser or light treatment, microdermabrasion, or superficial peels within 3 months Any facial cosmetic procedure with medium depth to deep facial chemical peels (e.g., trichloroacetic acid and phenol), midfacial or periorbital laser skin resurfacing or permanent makeup within 6 months Midfacial or periorbital treatment with nonpermanent soft tissue fillers Subjects planning a facial cosmetic procedure or visible scars Previous cosmetic surgery to the upper face(e.g., prior periorbital surgery, facial lift, brow lift, eyelid lift or eyebrow surgery) Diagnoses of Myasthenia Gravis, EatonLambert Syndrome, Amyotrophic Lateral Sclerosis History of facial nerve palsy A planned extended absence during the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>